Abbott Laboratories Poland sp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-08-27
Share capital
70,147,200.00 PLN
Registered address
Postępu 21B, 02-676 Warszawa, Poland
Electronic delivery address
AE:PL-99976-42584-WDIVD-23

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$1,588,243
Management board pay$80,494
Parent companyAbbott Holdings Poland Sp. z o.o.

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 91 days for 2021). All were audited by a statutory auditor.

  • 202507/08/2026
  • 202415/07/2025
  • 202314/07/2024
  • 202211/07/2023
  • 202114/10/2022
  • 202030/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods38 / 1,136
Top 3.4%
Division · Wholesale trade174 / 20,037
Top <1%
City · Warszawa358 / 56,729
Top <1%
Voivodeship · Mazowieckie456 / 76,892
Top <1%
Country · Poland1,261 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 174.51mMedianUSD 1.08mAverageUSD 22.54m
Net profit
This companyUSD 7.67mMedianUSD 39.26kAverageUSD 885.01k
Operating costs
This companyUSD 162.79mMedianUSD 963.92kAverageUSD 21.21m
Assets
This companyUSD 149.82mMedianUSD 610.11kAverageUSD 11.92m

Public procurement

168 tenders recorded as contractor: 60 national ($6,996,846) and 108 EU ($100,498,083), and 1 as contracting authority.

SubjectAmount
Supply of reagents for NGS, QPCR, mass spectrometer, cell selection, ammonia determination and IHC staining, together with lease of apparatus for nio-pib Oddział w Gliwicach
$13,258
D-45/2026 Supply of reagents together with the lease of integrated analyzers for the biochemical-immunological system for the needs of cla at Szpital Wielospecjalistyczny im dr. Ludwika Błażka w Inowrocławiu
$1.5M
Supply of reagents 5
$688.3K

Trademarks

The company currently holds no active trademarks with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2004.

MarkNumberClassesStatusProtected until
DISNEMAR XYLO (word)Z.4327645Proceedings discontinued –
Optium Omega Z.3273285, 6, 9, 10, 16, 20, 21, 25, 35, 41Not registered –
GlukoLink Z.2945535, 6, 9, 10, 16, 20, 21, 25, 28, 41Not registered –
MediSense. Możesz na nas liczyć. (word)Z.2908365, 6, 9, 10, 16, 20, 21, 25, 28, 41Proceedings discontinued –
Mark without a word element (figurative)Z.2845045, 6, 9, 10, 16, 20, 21, 25, 28, 41Not registered –
MarkProtected until
DISNEMAR XYLO (word)–
Optium Omega –
GlukoLink –
MediSense. Możesz na nas liczyć. (word)–
Mark without a word element (figurative)–

Authorized Representatives

Sylwia Beata Borowska-Kurek age 55 – President of the Management Board
Bradley Jay Slater – Management Board Member
Magdalena Dominika Śledziewska age 48 – Management Board Member

Manner of representation

Each of the members of the management board acting independently is authorized to represent the company, make declarations and sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
221,728$5,989,411.1331.609%
St. Jude Medical Luxembourg
479,744$12,959,049.1668.391%

Beneficial owners

Person

Capital group

The company belongs to the Abbott Laboratories (United States) group, which is its direct owner. The group has 143 companies, 141 of them abroad.

NameCountry
AbbottBelgium
Abbott (Jiaxing) Nutrition CO. Ltd.China
Abbott AGSwitzerland
Abbott Asia Holdings LimitedUnited Kingdom
Abbott Australasia PTY LtdAustralia

Bank accounts

Registered as a VAT taxpayer on 1998-03-01.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 468.9K

MSiG notices

Publication dateEvent
Jan 17, 2011Commercial Companies Code notice
Nov 3, 2010Merger plan

Public aid

No public aid cases recorded in the last 10 years.

European Funds

ProjectEU co-financing
Procurement of rapid antigene tests for diagnostic of covid-19
$6.1M

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Pfizer Trading Polska sp. z o.o.
Berlin-Chemie / Menarini Polska sp. z o.o.
Bristol-Myers Squibb Polska sp. z o.o.
Takeda Pharma sp. z o.o.
Natur Produkt Zdrovit sp. z o.o.
Astellas Pharma sp. z o.o.
Bialmed sp. z o.o.
Roche Diagnostics Polska sp. z o.o.
Servier Polska Services sp. z o.o.
Angelini Pharma Polska sp. z o.o.

Change history

DateEvent
2023-11-06Share capital increase
2019-01-02Share capital reduction
2015-02-02Share capital reduction
2010-12-31Share capital increase
2009-12-04Address change

FAQ

Last updated: 2026-08-07